Internal Medicine Alert – October 15, 2005
October 15, 2005
View Issues
-
Pharmacology Watch
The Use of Prophylactic Antibiotics for Neutropenia; Is It Hot In Here?; Homeopathy vs Conventional Medicine; FDA Actions -
Even If You Use It, You May Lose It!
The decline in VO2 in healthy adults is not constant across age spans but accelerates markedly with each successive age decade despite increases in leisure time physical activity. The decline in aerobic capacity is greater in men than women. -
Effect of a New Diagnosis of Barrett’s Esophagus on Insurance Status
Although patients with Barretts esophagus have a normal life expectancy, diagnosis of Barretts esophagus more than doubles life insurance premiums and may limit or prevent access to health insurance. -
Increased Dietary Intake of Folate Reduces the Risk of Developing Alzheimer’s Disease
An increased dietary intake of folate reduces the risk of developing AD. -
Pharmacology Update: Ramelteon Tablets (Rozerem)
The FDA has approved the first melatonin receptor agonist for the treatment of insomnia. Ramelteon differs from benzodiazepine and nonbenzo-diazepine sedative hypnotics in that it is a non-scheduled drug and it is approved for long term use. It is marketed by Takeda Pharmaceutical America, Inc as Rozerem. -
Clinical Briefs By Louis Kuritzky, MD
Gabapentin for Hot Flashes for Women with Breast Cancer; CHF: Risk-Treatment Mismatch; Diagnosing DPN: The Tuning Fork Wins! -
ECG Review: When Did the Chest Pain Begin?
The ECG in the Figure was obtained from a 50-year-old man who presented to the office for evaluation of chest pain. His symptoms began 5 days before the ECG shown here was recorded. The patients chest pain was initially severe, and had lasted about 2 daysbut then resolved. -
Clinical Briefs in Primary Care supplement